These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2499133)
1. [5-aminosalicylic acid in the long-term treatment of ulcerative colitis]. Breuer N Z Gastroenterol; 1989 Apr; 27(4):234-5. PubMed ID: 2499133 [No Abstract] [Full Text] [Related]
2. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission. Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895 [No Abstract] [Full Text] [Related]
3. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Dew MJ; Hughes P; Harries AD; Williams G; Evans BK; Rhodes J Br Med J (Clin Res Ed); 1982 Oct; 285(6347):1012. PubMed ID: 6127137 [No Abstract] [Full Text] [Related]
4. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial. Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408 [TBL] [Abstract][Full Text] [Related]
5. Oral mesalamine for ulcerative colitis. Med Lett Drugs Ther; 1992 Aug; 34(877):80-1. PubMed ID: 1353858 [No Abstract] [Full Text] [Related]
6. [Prevention of recurrence of chronic inflammatory bowel diseases]. Dölle W; Hartmann F Verh Dtsch Ges Inn Med; 1989; 95():322-6. PubMed ID: 2574922 [No Abstract] [Full Text] [Related]
7. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis. Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857 [TBL] [Abstract][Full Text] [Related]
8. Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth. Dew MJ; Harries AD; Evans N; Evans BK; Rhodes J Br Med J (Clin Res Ed); 1983 Jul; 287(6384):23-4. PubMed ID: 6134565 [No Abstract] [Full Text] [Related]
9. Oral asacol in the treatment of mild to moderate ulcerative colitis: the Nashville experience. Pruitt RE; Gremillion DE; Herring RW; Bailey AH; Faust TW; Potter M; Long KM J Tenn Med Assoc; 1991 May; 84(5):237. PubMed ID: 2067380 [No Abstract] [Full Text] [Related]
10. Oral balsalazide (Colazal) for ulcerative colitis. Med Lett Drugs Ther; 2001 Jul; 43(1109):62-3. PubMed ID: 11468602 [No Abstract] [Full Text] [Related]
11. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Baker DE; Kane S Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719 [TBL] [Abstract][Full Text] [Related]
12. Mesalamine for ulcerative colitis. Med Lett Drugs Ther; 1988 May; 30(766):53-4. PubMed ID: 3283508 [No Abstract] [Full Text] [Related]
13. [5-Aminosalicylic acid--a new therapeutic possibility in chronic inflammatory bowel disease]. Hartmann F Leber Magen Darm; 1986 Jan; 16(1):20-7. PubMed ID: 3515082 [No Abstract] [Full Text] [Related]
14. 5-ASA for ulcerative colitis. Meyers S; Janowitz HD N Engl J Med; 1988 Jun; 318(24):1620-1. PubMed ID: 3287160 [No Abstract] [Full Text] [Related]
15. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas. Barber GB; Lee DE; Antonioli DA; Peppercorn MA Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789 [TBL] [Abstract][Full Text] [Related]
16. Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study. Bianchi Porro G; Ardizzone S; Petrillo M; Fasoli A; Molteni P; Imbesi V Am J Gastroenterol; 1995 May; 90(5):736-9. PubMed ID: 7733079 [TBL] [Abstract][Full Text] [Related]
17. [Long-term therapy and timing of surgical intervention in ulcerative colitis and Crohn disease]. Goebell H; Eigler FW Chirurg; 1992 Jan; 63(1):8-12. PubMed ID: 1347737 [No Abstract] [Full Text] [Related]
18. Caution in the interpretation of safety and efficacy differences in clinical trials comparing aminosalicylates for ulcerative colitis. Hanauer SB Am J Gastroenterol; 2003 Jan; 98(1):215-6. PubMed ID: 12526968 [No Abstract] [Full Text] [Related]
19. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. d'Albasio G; Pacini F; Camarri E; Messori A; Trallori G; Bonanomi AG; Bardazzi G; Milla M; Ferrero S; Biagini M; Quaranta S; Amorosi A Am J Gastroenterol; 1997 Jul; 92(7):1143-7. PubMed ID: 9219787 [TBL] [Abstract][Full Text] [Related]
20. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Campieri M; Lanfranchi GA; Bazzocchi G; Brignola C; Sarti F; Franzin G; Battocchia A; Labo G; Dal Monte PR Lancet; 1981 Aug; 2(8241):270-1. PubMed ID: 6114321 [No Abstract] [Full Text] [Related] [Next] [New Search]